Details for New Drug Application (NDA): 202562
✉ Email this page to a colleague
The generic ingredient in DACTINOMYCIN is dactinomycin. There are three drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the dactinomycin profile page.
Summary for 202562
Tradename: | DACTINOMYCIN |
Applicant: | Am Regent |
Ingredient: | dactinomycin |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 202562
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 0.5MG/VIAL | ||||
Approval Date: | Aug 23, 2013 | TE: | RLD: | No |
Complete Access Available with Subscription